JPRN-jRCT2080222137未知2 期
K-104-CR Phase II Exploratory study
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with hypercholesterolemia
排除标准
- •Those complicated with Type 1 diabetes mellitus or poorly controlled Type 2 diabetes mellitus
- •Those complicated with poorly controlled hypertension
- •Those complicated with poorly controlled thyroid disorder
- •Those complicated with renal disorder
- •Those complicated with muscular disorder
研究者
相似试验
未知
2 期
KRP-104Phase 2 Dose Finding Study -Investigation on Type2 Diabetes MellitusJPRN-jRCT2080220708Kyorin Pharmaceutical Co.,LTD
未知
2 期
K012 phase II clinical studyColorectal cancerJPRN-jRCT2080220752ippon Kayaku Co., Ltd.
未知
2 期
Exploratory Phase II Study of KRP-203 -A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of KRP-203 in Patients with Crohn's Disease in Active PhaseCrohn's DiseaseJPRN-jRCT2080222062Kyorin Pharmaceutical Co.,LTD60
未知
2 期
KD-357 Phase II/III Studypreexposure prophylaxis against rabiesJPRN-jRCT2080222295The Chemo-Sero-Therapeutic Research Institute30
未知
2 期
KD-370 Phase II study.The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.JPRN-jRCT2080222866The Chemo-Sero-Therapeutic Research Institute